Vétoquinol posts strong 2014 sales and earnings trends; Cox recalls equine ulcer remedy in response to FDA warning;

> The Vétoquinol Group announced that 2014 sales rose 5.2% in 2014 to €315.3 million ($354.4 million), with strong growth in both livestock and pet products across all of its sales territories. Release (PDF)

> Cox Veterinary Laboratory voluntarily recalled Gastroade Xtra, an over-the-counter ulcer treatment for horses containing the heartburn drug omeprazole, in response to FDA warnings that the product was being illegally marketed. Release

> Phibro Animal Health ($PAHC) has acquired North American distribution rights to vaccines that use technology developed by MJ Biologicals, as well as some related intellectual property and other assets. Release

> India's animal health company Hester Biosciences announced that sales in its third quarter rose 38% year over year to 218.8 million rupees ($3.6 million) and net profit jumped 32% to 33.7 million rupees ($547,863). Release (PDF)

> J.J. Fuds has recalled certain lots of its Chicken Tender Chunks Pet Food because of possible contamination with Listeria monocytogenes. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…